文献速递肺结节与肺癌

IA期非小细胞肺癌消融与肺叶切除术结局比较:回顾性多中心研究

Comparison of Outcomes Between Ablation and Lobectomy in Stage IA Non-Small Cell Lung Cancer: A Retrospective Multicenter Study.
PubMed 文献 · Respirology · 2025-08-28

该回顾性多中心研究经倾向性评分匹配纳入290例IA期NSCLC患者,比较影像引导热消融(IGTA)与肺叶切除术的长期结局。两组5年PFS(HR 1.83,95%CI 0.86-3.92,p=0.118)和OS(HR 2.44,95%CI 0.87-6.63,p=0.092)无显著差异;低收入地区肺叶切除术在99%模拟中不具成本效益;基于CT的影像组学模型AUC 0.759优于TNM模型0.650(p<0.01),高危组无病生存显著低于低危组(p=0.009)。结论提示IGTA对经仔细选择的患者可能是安全可行的替代方案。

要点

  • 匹配后IA期NSCLC患者中,IGTA与肺叶切除术的5年PFS和OS无显著差异。
  • 低收入地区肺叶切除术在99%模拟中不具成本效益。
  • 基于CT的影像组学模型可进行风险分层,高危组无病生存显著更差。

核心结论

  • IGTA对经仔细选择的IA期NSCLC患者可能是安全可行的传统手术替代方案。

研究设计与样本

  • 回顾性多中心研究,经倾向性评分匹配后纳入2015至2023年290例IA期NSCLC患者。
  • 采用Kaplan-Meier法估计无进展生存期(PFS)和总生存期(OS),构建Markov模型评估成本效益,并开发基于术前CT的影像组学模型进行风险分层。

主要发现

  • 匹配后肺叶切除组中位随访34.8个月,消融组47.2个月。
  • 两组5年PFS无显著差异(HR 1.83,95%CI 0.86-3.92,p=0.118)。
  • 两组OS无显著差异(HR 2.44,95%CI 0.87-6.63,p=0.092)。
  • 低收入地区肺叶切除术在99%模拟中不具成本效益。
  • 基于CT的影像组学模型AUC 0.759优于传统TNM模型0.650(p<0.01),高危组无病生存显著低于低危组(p=0.009)。

临床怎么用

  • 对于经仔细选择的IA期NSCLC患者,IGTA可作为肺叶切除术的替代选择。
  • 在低收入地区,可结合成本效益分析考虑IGTA。
  • 基于术前CT的影像组学模型可用于风险分层,辅助识别可能从消融中获益的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Image-guided thermal ablation (IGTA) has been increasingly used in patients with stage IA non-small cell lung cancer (NSCLC) without surgical contraindications, but its long-term outcomes compared to lobectomy remain unknown. This study aims to evaluate the long-term outcomes of IGTA versus lobectomy and explore which patients may benefit most from ablation. METHODS: After propensity score matching, a total of 290 patients with stage IA NSCLC between 2015 and 2023 were included. Progression-free survival (PFS) and overall survival (OS) were estimated using the Kaplan-Meier method. A Markov model was constructed to evaluate cost-effectiveness. Finally, a radiomics model based on preoperative computed tomography (CT) was developed to perform risk stratification. RESULTS: After matching, the median follow-up intervals were 34.8 months for the lobectomy group and 47.2 months for the ablation group. There were no significant differences between the groups in terms of 5-year PFS (hazard ratio [HR], 1.83; 95% CI, 0.86-3.92; p = 0.118) or OS (HR, 2.44; 95% CI, 0.87-6.63; p = 0.092). In low-income regions, lobectomy was not cost-effective in 99% of simulations. The CT-based radiomics model outperformed the traditional TNM model (AUC, 0.759 vs. 0.650; p < 0.01). Moreover, disease-free survival was significantly lower in the high-risk group than in the low-risk group (p = 0.009). CONCLUSION: This study comprehensively evaluated IGTA versus lobectomy in terms of survival outcomes, cost-effectiveness, and prognostic prediction. The findings suggest that IGTA may be a safe and feasible alternative to conventional surgery for carefully selected patients.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Xu B, Chen Z, Liu D, et al. Comparison of Outcomes Between Ablation and Lobectomy in Stage IA Non-Small Cell Lung Cancer: A Retrospective Multicenter Study. Respirology. 2025. PMID: 40878040. doi:10.1111/resp.70116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。